Jason Cavalier - Feb 12, 2022 Form 4 Insider Report for Lyra Therapeutics, Inc. (LYRA)

Role
Chief Financial Officer
Signature
/s/ Jason Cavalier
Stock symbol
LYRA
Transactions as of
Feb 12, 2022
Transactions value $
$0
Form type
4
Date filed
2/15/2022, 08:30 PM
Previous filing
Sep 15, 2021
Next filing
Feb 2, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LYRA Stock Option Award $0 +15.6K $0.00 15.6K Feb 12, 2022 Common Stock 15.6K $4.78 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests and becomes exercisable in 48 equal monthly installments occurring on the completion of each successive month of the Reporting Person's service to the Issuer following February 12, 2022.

Remarks:

Exhibit 24 - Power of Attorney